The aim is to develop so-called exascale computing systems. These get their name from one exaflops or floating point operations per second, processing performance which is x1,000 a petaflops.
Intel’s aim is to develop exascale-level computing technology by 2018.
It is anticipated that this level of computing power will be used in biochemical drugs and DNA research. Other areas include quantum physics, climate research and biological modeling.
The BSC Exascale Laboratory will research scalable parallel run-time systems that are needed to support these very high levels of parallel computing.
“BSC is one of Europe’s most renowned HPC labs and offers very interesting technology to scale run time systems, tools and applications up to exascale level,” said Stephen Pawlowski, Intel senior fellow.
The laboratory will employ about a dozen R&D professionals and augment Intel’s European exascale R&D strategy.
Intel exascale computing research centres in Paris, Jülich (Germany) and Leuven (Belgium).
All four European exascale R&D centers will seek close collaboration among each other as well as with the CERN openlab in Geneva (Switzerland).
In all Intel currently has 25 R&D centres in Europe employing more than 1,500 researchers.